The company expects that this development could improve the strength of its application to the FDA for new drug approval
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Investment is additive to KKR’s existing health care growth strategy
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Subscribe To Our Newsletter & Stay Updated
